| | |
Mark to Market | Manas Chakravarty and Mobis Philipose 01:15 AM | August 14,2009
Revenue from products manufactured by Caraco fell by 59% to $13.1 million and that from products that are manufactured as well as distributed by Sun Pharma fell 54% to $35 million
|
|
Sumeet Chatterjee / Reuters 01:00 PM | August 12,2009
Sun Pharma will share a 180-day marketing exclusivity for oxaliplatin with three other generic makers, the Indian firm said
|
|
C.H. Unnikrishnan and Radhieka Pandeya 12:34 AM | June 27,2009
Sun, India’s largest drug maker by market value, has a 76% stake in Caraco
|
|
Lison Joseph 12:14 AM | April 06,2009
Bill proposes to put in place a more rigorous inspection procedure; may help make pharma firms more competitive
|
|
Ashwin Ramarathinam 02:12 AM | February 12,2009
List of firms whose promoters have pledged their shares to banks and other financial institutions
|
|
C.H. Unnikrishnan and Radheika Pandeya 01:00 AM | January 06,2009
The Indian company has offered to revise the offer price to $9 per share if Taro withdraws an injunction on Sun’s open offer for the Israeli firm’s shares in the US
|
|
PTI 11:19 AM | December 24,2008
The pharma sector saw hefty excise duty cuts, foreign firms acquiring domestic ones, legal tussles against the US FDA ban on import of some drugs
|
|
03:02 PM | July 06,2008
Infosys, Sun Pharma and Ranbaxy top the list of firms in terms of absolute growth in market value of shares
|
|
C.H. Unnikrishnan 12:09 AM | June 27,2008
Sun Pharmaceuticals CMD says the exercise of the options should not in any way be construed to be an acceptance or recognition of the termination of the merger agreement
|
|
C.H. Unnikrishnan 12:03 AM | June 27,2008
Under the May 2007 agreement, Sun has the right to buy shares owned or controlled by Levit and other controlling shareholders at $7.75 per share
|
|
10:39 AM | December 17,2007
The collective market capitalisation of new research entities is estimated to touch $120 billion in less than a decade
|
|
C.H. Unnikrishnan 12:14 AM | November 23,2007
The challenge weakens Novartis’ petition against an Indian ruling denying patent for the Swiss firm’s cancer drug
|
|
Bhuma Shrivastava 11:10 PM | October 16,2007
One-off opportunities in drug launches and huge foreign currency loans will shield companies such as Ranbaxy Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Lupin Ltd and Jubilant Organosys Ltd
|
|
07:32 PM | August 26,2007
Taro Pharma shareholders find Sun Pharma’s offer price unacceptable, resist deal
|
|